Risk-adapted, Proteomic-guided Systemic Therapy for Previously Untreated Advanced Non-small Cell Lung Cancer

Clinical trial NCT07250477 · RECRUITING

Trial details

NCT number: NCT07250477
Sponsor: University of California, Davis
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Stage IIIC Non-small Cell Lung Cancer Stage IV Non Small Cell Lung Cancer Non-small Cell Lung Cancer Metastatic Non-small Cell Lung Cancer Unresectable

Start date: 2026-01-30
Primary completion: 2036-05-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.